BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +2 vs. Q1 2024
- Shares held
- 16.4M
- +311.1K (+1.9%) vs. Q1 2024
- Total value
- $167.4M
- +$523.6K (+0.3%) vs. Q1 2024
- New holders
- 2
- 5 more added
- Sold out
- 0
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 2,909,000 | $29.7M | 1.73% | 00.0% | Unchanged |
| BlackRock Inc. | 1,500,000 | $15.3M | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,400,000 | $14.3M | 0.03% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,332,508 | $13.6M | 0.01% | +550.0% | Added |
| Price T Rowe Associates Inc | 1,130,677 | $11.6M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 1,117,400 | $11.4M | 0.01% | +11,610+1.0% | Added |
| Sculptor Capital LP | 705,000 | $7.21M | 0.15% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 600,000 | $6.13M | 0.04% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 500,000 | $5.11M | 0.12% | 00.0% | Unchanged |
| Great Point Partners LLC | 500,000 | $5.11M | 0.98% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 500,000 | $5.11M | 1.26% | 00.0% | Unchanged |
| Commodore Capital LP | 500,000 | $5.11M | 0.35% | 00.0% | Unchanged |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 475,000 | $4.85M | 0.11% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 404,138 | $4.13M | 0.83% | +638+0.2% | Added |
| T. Rowe Price Investment Management, Inc. | 400,000 | $4.09M | 0.00% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 300,000 | $3.07M | 1.07% | 00.0% | Unchanged |
| Laurion Capital Management LP | 300,000 | $3.07M | 0.10% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 250,000 | $2.56M | 0.40% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 250,000 | $2.56M | 0.42% | 00.0% | Unchanged |
| StemPoint Capital LP | 200,000 | $2.04M | 0.60% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 189,285 | $1.93M | 0.00% | 00.0% | Unchanged |
| Wellington Management Group LLP | 184,670 | $1.89M | 0.00% | −17,490−8.7% | Reduced |
| Acuta Capital Partners, LLC | 177,836 | $1.82M | 1.53% | +177,836 | New |
| TD Asset Management Inc | 144,772 | $1.48M | 0.00% | +144,772 | New |
| Woodline Partners LP | 103,247 | $1.06M | 0.01% | −3,458−3.2% | Reduced |
| Moore Capital Management, LP | 100,000 | $1.02M | 0.02% | 00.0% | Unchanged |
| Walleye Capital LLC | 92,864 | $949.1K | 0.01% | +640+0.7% | Added |
| Walleye Trading LLC | 52,236 | $533.9K | 0.01% | +360+0.7% | Added |
| Cowen and Company, LLC | 50,511 | $516.2K | 0.01% | −3,902−7.2% | Reduced |
| Geode Capital Management, LLC | 10,869 | $111.1K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 4 | $41 | 0.00% | 00.0% | Unchanged |